Obesity Pillars
Издатель: Elsevier · ISSN 2667-3681 · 77 статей
- Clinical-genetic predisposition and medium-term outcomes after bariatric surgery: A 5-year validation of the OBEGEN score
- GLP-1 and GLP-1/GIP receptor agonist medication use and self-reported outcomes in individuals with lipedema: Results from a large online survey
- Differences in body composition and physical activity in youth with obesity who report pain
- Virtual shared medical appointments for obesity and GLP-1 medications: A scalable method for optimizing care delivery
- Obesity and pelvic organ prolapse: Review
- Real-world treatment satisfaction and experience with once-weekly tirzepatide: Insights from prescribing physicians and people with obesity or overweight
- Hidden nutritional inadequacy in U.S. children with obesity: Evidence from National Health and Nutrition Examination Survey 2021–2023
- Research priorities for psychosocial interventions in obesity care: Outcomes from a Canadian research summit
- Using Early and Periodic Screening, Diagnostic, and Treatment (EPSDT) to improve access to obesity pharmacotherapy: A practical guide for clinicians caring for youth with obesity across United States Medicaid programs: Abbreviated title: Using EPSDT to Improve Access to Obesity Pharmacotherapy
- Micronutrient risk with GLP-1 receptor and dual incretin agonists in obesity: Mechanistic pathways, clinical signals, and a monitoring framework
- Nutritional considerations for glucagon-like peptide-based therapies: An Asian Indian consensus recommendation
- Prevalence of overweight and obesity and associated factors among persons with type 2 diabetes mellitus in Ethiopia: A systematic review and meta-analysis
- Obesity and Women's health across the lifespan: A clinical review of life Stage–Specific challenges and treatment considerations
- Resolution of anhedonia-like symptoms in patients treated for obesity with tirzepatide: A three-case series
- Nutritional deficiencies should be systematically assessed as potential adverse effects in incretin-based obesity therapies
- Corrigendum to “Impact of tirzepatide on systemic arterial stiffness assessed by cardio-ankle vascular index in individuals with obesity complicated by type 2 diabetes: A retrospective cohort study in Japan” [Obesity Pillars 19 (2026) 100291]
- Corrigendum to “Nutritional considerations for glucagon-like peptide-based therapies: An Asian Indian consensus recommendation” [Obesity Pillars 19 (2026) 100296]
- Effects of Twelve Weeks of Exercise Snacks and Time-Restricted Eating on Body Composition, Adipokines, and FGF21 in Sedentary Men with Overweight or Obesity: A Randomized Controlled Trial
- Dietary Protein Intake Relative to Adult and Older-Adult Reference Intakes in Type 2 Diabetes, by Use of Glucagon-Like Peptide-1 Receptor Agonists: A Nationally Representative Cross-Sectional Study
- Obesity and Cardiovascular Disease: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2026
- Population meeting surveillance-based thresholds for metabolic and bariatric surgery evaluation under the 1991 NIH and 2022 ASMBS/IFSO criteria across 37 settings: STEPS analysis and projections to 2030
- Specialty-based variation in glucagon-like Peptide-1 receptor agonist prescribing practices for adolescent obesity in Saudi Arabia
- Effectiveness of dietary, physical activity, and lifestyle interventions on weight and cardiometabolic outcomes in adults with overweight or obesity: an umbrella review of 112 systematic reviews and meta-analyses from 50 countries
- Genetic variants of the leptin–melanocortin pathway in a clinically selected Greek cohort with severe early-onset obesity and hyperphagia: implications for precision obesity medicine
- Agreement between people with obesity and their treating physicians on behavioral and psychological phenotypes in real-world obesity care
- Association between diet quality and overweight or obesity among adults with type 2 diabetes at Debre Markos Comprehensive Specialized Hospital, Northwest Ethiopia
- Evaluation of clinical relevance of weight nadirs and weight regain during 3 years of treatment with tirzepatide in participants with obesity or overweight and prediabetes
- Patient expectations and healthcare professional education in obesity care: A comparative qualitative study
- Hope, hype, and high costs: Navigating glucagon-like Peptide-1 based therapy initiation among young adults
- Prevalence and associated factors of overweight/obesity and central obesity among adults receiving dolutegravir-based first-line treatment in health facilities at hawassa city administration, sidama region